Vascular endothelial growth factor receptor 1 (FLT1) Antibody

Este producto es parte de FLT1 - fms related receptor tyrosine kinase 1
Product Graph
221€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Vascular endothelial growth factor receptor 1 (FLT1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx326693
tested applications
ELISA, WB, IHC

Description

FLT1 Antibody is a Rabbit Polyclonal against FLT1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetVascular endothelial growth factor receptor 1 (FLT1)
HostRabbit
ReactivityHuman, Mouse, Rat
Recommended DilutionELISA: 1/5000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
IsotypeIgG
PurificationPurified by affinity chromatography.
Size 150 µg
Size 2100 µg
FormLiquid
Tested ApplicationsELISA, WB, IHC
BufferPBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
AvailabilityShipped within 5-10 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP17948
Gene ID2321
AliasFLT,FLT-1,VEGFR1,VEGFR-1,Vascular permeability factor receptor,Fms-like tyrosine kinase 1,Vascular endothelial growth factor receptor 1
BackgroundAntibody anti-FLT1
StatusRUO

Descripción

Fms related receptor tyrosine kinase 1 (FLT1) FLT1, also known as vascular endothelial growth factor receptor 1 (VEGFR1), is a transmembrane tyrosine kinase receptor that binds vascular endothelial growth factors (VEGFs) and placental growth factor (PlGF). FLT1 plays a crucial role in angiogenesis, vascular development, and inflammation by regulating endothelial cell proliferation, migration, and survival. Structurally, FLT1 consists of an extracellular ligand-binding domain with seven immunoglobulin-like loops, a transmembrane domain, and an intracellular kinase domain. FLT1 can function as a signaling receptor or a decoy receptor, depending on its membrane-bound or soluble isoforms, modulating VEGF availability and signaling intensity. It is highly expressed in endothelial cells and trophoblasts, contributing to processes such as placental development and vascular remodeling. Dysregulation of FLT1 is implicated in pathological conditions, including cancer, where it promotes tumor angiogenesis, and preeclampsia, where excessive FLT1 activity leads to impaired placental and vascular function. Its dual role as a regulator of VEGF signaling and a therapeutic target underscores its importance in both physiological and pathological angiogenesis.

Related Products

EH0024

Human VEGFR1(Vascular Endothelial Growth Factor Receptor 1) ELISA Kit

Ver Producto
EM1028

Mouse FLT1/VEGFR1(Vascular Endothelial Growth Factor Receptor 1) ELISA Kit

Ver Producto
EP0164

Porcine VEGFR1/Flt1(Vascuoar Endothelial Growth Factor Receptor 1) ELISA Kit

Ver Producto